Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
139 hedge funds and large institutions have $835M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 24 closing their positions.
228% more capital invested
Capital invested by funds: $255M → $835M (+$580M)
142% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 24
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
78% more call options, than puts
Call options by funds: $20.1M | Put options by funds: $11.3M
32% more funds holding
Funds holding: 105 → 139 (+34)
28% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$17.2M |
| 2 |
WIC
Water Island Capital
New York
|
+$16.5M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$15M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$13.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$13.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$40.7M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$21.9M |
| 3 |
EPL
EDBI Pte Ltd
Singapore
|
-$16M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$14.3M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$6.6M |
FMTX Hedge Fund Activity: Q3 2022 in Review
139 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q3 2022, worth a combined $835M — up 228% from $255M a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new FMTX positions and 24 closed out — a net gain of 34 holders — while 37 added to existing stakes and 29 trimmed.
The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $17.2M. The largest seller was Deep Track Capital, cutting an estimated $40.7M.
- 139 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q3 2022, up from 105 in Q2 2022.
- Funds reported $835M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q3 2022, up 228% quarter-over-quarter.
- 58 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q3 2022 and 24 closed out, a net change of +34 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q3 2022 was TIG Advisors LLC, an estimated $17.2M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q3 2022 was Deep Track Capital, an estimated $40.7M sold.
Based on aggregated 13F filings for Q3 2022.